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Abstract
Boid Inclusion Body Disease (BIBD) is a potentially fatal disease reported in captive boid
snakes worldwide that is caused by reptarenavirus infection. Although the detection of intra-
cytoplasmic inclusion bodies (IB) in blood cells serves as the gold standard for the ante mor-
tem diagnosis of BIBD, the mechanisms underlying IB formation and the pathogenesis of
BIBD are unknown. Knowledge on the reptile immune system is sparse compared to the
mammalian counterpart, and in particular the response towards reptarenavirus infection is
practically unknown. Herein, we investigated a breeding collection of 70 Boa constrictor
snakes for BIBD, reptarenavirus viraemia, anti-reptarenavirus IgM and IgY antibodies, and
population parameters. Using NGS and RT-PCR on pooled blood samples of snakes with
and without BIBD, we could identify three different reptarenavirus S segments in the collec-
tion. The examination of individual samples by RT-PCR indicated that the presence of Uni-
versity of Giessen virus (UGV)-like S segment strongly correlates with IB formation. We
could also demonstrate a negative correlation between BIBD and the presence of anti-UGV
NP IgY antibodies. Further evidence of an association between antibody response and
BIBD is the finding that the level of anti-reptarenavirus antibodies measured by ELISA was
lower in snakes with BIBD. Furthermore, female snakes had a significantly lower body
weight when they had BIBD. Taken together our findings suggest that the detection of the
UGV-/S6-like S segment and the presence of anti-reptarenavirus IgY antibodies might
serve as a prognostic tool for predicting the development of BIBD.
Introduction
Boid inclusion body disease (BIBD) is a widespread disease of captive boid snakes known
since the 1970s [1–3]. The disease is characterised by the presence of eosinophilic and
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electron-dense intracytoplasmic inclusion bodies (IBs) in most cell types of affected snakes [1–
3]. In the early 2010s, we and others identified arenaviruses as the most likely causative agents
of BIBD, by demonstrating that the IBs consist mainly of arenavirus nucleoprotein [4–7]. The
causative link was later confirmed by experimental infection of boas and pythons with reptare-
navirus isolates [8]. The family Arenaviridae in the order Bunyavirales currently comprises
four genera: Mammarenavirus, Reptarenavirus, Hartmanivirus, and Antennavirus [9]. The are-
naviruses found in snakes with BIBD belong to the genera Reptarenavirus and Hartmanivirus
[9].
The genome of reptarenaviruses is a bi-segmented single-stranded negative-sense RNA
with ambisense coding strategy. The small (S) segment encodes the nucleoprotein (NP) and
the glycoprotein precursor (GPC), while the matrix protein (ZP) and the RNA-dependent
RNA polymerase (RdRp) are encoded by the large (L) segment [10]. The genome of hartmani-
viruses is similar, except that it lacks the ZP [10]. Snakes with BIBD are commonly co-infected
with several reptarenaviruses, and, curiously, they often harbour more L than S segments
[1,11,12]. The co-existence of multiple segments in an infected snake likely allows re-assort-
ment of L and S segments [12]. The genetic variation between the known reptarenaviruses is
tremendous and up to now L segments of approximately 30 different reptarenavirus species
are known [1,10–12]. The genetic dissimilarity significantly hampers the development of sensi-
tive “pan-reptarenavirus” RT-PCR tools. Therefore, since the IBs occur in blood cells including
erythrocytes, IB detection in blood smears represents the current gold standard for ante mor-
tem BIBD diagnosis [3,13]. However, the presence of IBs does not associate with pathological
changes or clinical signs, and thus snakes with reptarenavirus infection can remain clinically
healthy for a long time [4,8]. Subclinical infections together with horizontal and vertical trans-
mission of reptarenaviruses [1,12] are the likely reasons behind reptarenavirus co-infections
being rather a rule than an exception in snakes with BIBD.
Despite the above facts, BIBD appears to be ultimately lethal [1–3]. Clinical features
observed in snakes with BIBD include neurological signs, regurgitation, anorexia, pneumonia,
stomatitis, and lymphoproliferative disorders [2,13,14]. The pathogenesis is poorly under-
stood, however, the fact that bacterial infections and/or neoplastic processes are common in
snakes with BIBD suggests that the disease is associated with immunosuppression [2–4]. Lym-
phocytic choriomeningitis virus (LCMV), the prototype arenavirus (genus Mammarenavirus),
induces immunosuppression by inhibition of type I interferon (IFN-I) production [15–17].
The underlying mechanism is prevention of the RIG-I(retinoic acid inducible gene-I)/MAVS
(mitochondrial antiviral signaling) pathway by the NP of LCMV [10,17]. The IFN-I produc-
tion is further inhibited by the ZP of LCMV, which enters the nucleus and induces re-localisa-
tion of promyelocytic leukemia (PML) bodies to the cytoplasm [10,18,19]. Intriguingly, PML
bodies contribute to tumour suppression which is hampered by their cytoplasmic localisation
[20], thus the ZP of reptarenaviruses could promote tumourigenesis by such a mechanism.
Additionally, the ZP of New World arenaviruses prevents the type I IFN response by binding
to RIG-I [17].
Currently, not much is known about the immune response of snakes to reptarenaviruses.
In fact, the knowledge of the reptile immune response in general is scarce, mainly relying on
individual studies undertaken on different species [21]. It has been shown that like all verte-
brates, reptiles mount an innate and adaptive immune response, comprising both humoral
and cell-mediated factors [21,22]. Like in mammals, the humoral branch of the reptile innate
immune system relies heavily on antimicrobial peptides and proteins as well as the comple-
ment pathway [21]. Reptiles have equivalents of interleukins (IL), IFNs and Toll-like receptors
and can therefore coordinate their immune response, however, in vitro studies show the reptile
system to be temperature and hormone dependent [21,23–28]. Also, in contrast to mammals
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with their cytokine-mediated development of fever, snakes are poikilotherm and thus increase
their body temperature behaviourally by exposing themselves to higher environmental tem-
peratures as demonstrated by stimulation with bacterial LPS or infection with gram-negative
bacteria [21,29,30].
The adaptive immune response of both mammals and reptiles has a cell-mediated and a
humoral component. The former is based on T cells, and in reptiles their proliferation depends
on the seasonal cycle [31–33]. Females show a stronger cell-mediated immunity than males in
both mammals and reptiles [21,34–36], and in the latter T cell proliferation is stronger in non-
gravid than in gravid animals [21,36]. In vertebrates, including reptiles, the immunoglobulins
(Ig) orchestrate the humoral branch of the adaptive immune system. Reptiles produce Igs of
three classes, IgY, IgM and IgD; the leopard gecko (Eublepharis macularius), for example, also
produces IgA [21,37]. The reptile IgM is considered as equivalent to IgM of other vertebrates,
and IgY corresponds to mammalian IgG [22,38]; the molecular features are similar. Depend-
ing on the snake species IgY may occur in three isotypes, a, b, and c. According to sequence
analysis, the IgY isotypes of boid snakes differ from those of other snake species but show
structural similarity to mammalian IgG in that the heavy and light chains are covalently bound
[37]. In both reptiles and mammals exposure to an infectious agent (or other foreign antigen)
triggers IgM production approximately within a week [21]. In mammals IgM appears around
10 days [21] and peaks around 10–14 days post exposure. In reptiles, serum IgM levels reach
the peak much later, up to 8 weeks post exposure, indicating differences in the maturation of
the adaptive immune response compared to mammals [14,21]. Depending on the species stud-
ied and the antigens used, the IgM response in reptiles can last up to 34 weeks after exposure
[21], whereas the IgY response appears around 31 days post exposure and can last for many
years, similar to the mammalian IgG response [39].
Overall, in comparison to mammals, the reptile antibody response is weaker [22] since the
titres do not necessarily increase after a second antigen exposure and there is a lack of affinity
maturation [21,22]. However, studies on colubrid snakes indicated an increase in titres after
repeated antigen exposure [40], and the rapidness of the response indicates immunological
memory [21,22,40]. Again, the reptile antibody response is affected by environmental and
individual factors such as temperature, season, sex, age, and the neuroendocrine status [14,22].
We set up this study to assess the antibody response against reptarenaviruses in snakes. Our
working hypothesis was that snakes with BIBD, i.e. with the presence of IBs in blood cells and
confirmed reptarenvirus infection, would show low anti-reptarenavirus antibody titres, if any.
We also wanted to study whether other measurable parameters, such as the sex, age, and
weight of the animals, or the number of reptarenaviruses infecting an individual snake could
be associated with IB formation. To answer these questions, we studied a cohort (N = 70) of
snakes in a single breeding collection with previously confirmed BIBD cases.
Results
Diagnosis of BIBD based on the cytological examination of blood smears
We based the BIBD diagnosis on the detection of IBs in cells in blood smears stained with
May-Gru¨nwald-Giemsa [7]. A similar approach was recently confirmed to correlate well with
immunological staining of peripheral white blood cells (PWBC) for reptarenavirus NP [41].
We confirmed the association of the IBs with reptarenavirus infection by RT-PCR (see below),
considering this as further proof of the disease and evidence that affected animals will eventu-
ally develop clinical signs [13]. We could detect IBs (Fig 1) in 34 of the 70 blood smears studied
(48.57%; BIBD-positive snakes; Table 1). In the remaining 36 snakes (51.43%) the blood cells
were free of IBs (BIBD-negative snakes; Table 2) [2]. At the time of blood sampling, all but the
Antibodies in BIBD
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two debilitated snakes and the animal with cloacal prolapse (animals 1.18, 1.20, 1.29) appeared
clinically healthy.
We examined the animals’ age and weight against the BIBD diagnosis (Table 3). The aver-
age age was 4.6 years (95%CI: 4.26–4.99). We did not find statistically significant differences in
age between female and male animals or between BIBD-positive and -negative animals. How-
ever, we found a statistically significant (p<0.01) association between BIBD and the weight of
the female animals: BIBD-positive female animals had significantly lower body weights (Fig 2);
the geometric mean of the weight was 3.077kg for the BIBD-positive female animals and 4.912
kg for the negative ones. The same association was not significant for male animals (Table 3).
Linear regression established that the weight of the animals was significantly associated with
age, sex and BIBD status (Table 4), F(3,63) = 39.67, and they accounted for 63.74% of weight
variability. The regression equation is: Predicted Weight = -0.177 + 0.084 age + 0.255 sex—
0.107 BIBD-positive.
Characterization of the breeding collection’s “reptarenavirome”
We and others have previously reported that snakes with BIBD often harbour several reptare-
navirus L and S segments; usually, more L than S segments are found in each snake [1,11,12].
To study whether the BIBD-negative snakes would also be free of reptarenavirus infection, we
performed a meta-transcriptomic analysis of pooled blood samples (one pool from three
snakes without evidence of IBs in blood cells, the other from three snakes with a high number
of IBs in blood cells). From the reads acquired by NGS of the BIBD-positive blood pool we
could assemble five reptarenavirus L segments and one S segment, as well as two pairs of hart-
manivirus L and S segments [10]. To our surprise, we could not assemble any full-length L or S
segments from the reads acquired from the BIBD-negative blood pool. However, using a map-
ping approach we identified some reads matching the L and S segments assembled from the
data of the BIBD-positive blood pool. We then decided to screen a further three pools of three
blood samples by RT-PCR, using virus-specific primers from our earlier study [1], one pool
from BIBD-negative snakes, two from BIBD-positive snakes. We found the S segments of
Fig 1. May-Gru¨nwald-Giemsa stained blood smear, BIBD-positive snake (animal no. 1.25). Erythrocytes frequently
exhibit intracytoplasmic inclusion bodies (arrows).
https://doi.org/10.1371/journal.pone.0221863.g001
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UGV-2, S5-like, and TSMV-2 to be present in the positive pools, while the negative pool was
only positive for the latter two. The L segment profiles of the pools seemed variable.
We analysed the population parameters against the RT-PCR test results for associations
with the detection of hartmaniviruses (OScV-1 and -2). OScV-1 detection did not significantly
associate with any of the population parameters, while OScV-2 detection positively associated
with age. The average age of animals without OScV-2 infection was 4.28 years (n = 50, 95%CI:
Table 1. Animals with BIBD included into the study (diagnosis based on the detection of intracytoplasmic inclusion bodies in blood cells, using blood smears).
Animal (number) Age (years) Sex Weight (kg) S segment WB ELISA
UGV-1 UGV-1 UHV NP UHV NP-C
UGV-2 S5-like TSMV-2 IgY IgM IgY IgM IgY IgM IgY IgM
1.01 2 M 1.10 + + + - - - + - - - -
1.02 2 M 2.10 + + + ++ ++ - + - - - -
1.03 3 M 1.40 + + + + ++ - - - - - -
1.04 3 M 1.80 + + - ++ + + + - - - -
1.05 3 M 3.00 + + - - + - - + - + -
1.06 3 F 1.00 + + - ++ + - - - - - -
1.07 3 F 1.50 + - - +++ +++ + + + + + +
1.08 4 M 1.40 + + + + + - + - - - -
1.09 4 M 1.60 + + + +++ - - + - - - -
1.10 4 M 2.20 + + + ++ +++ - - - - - -
1.11 4 F 2.50 + + - - - - - - - - -
1.12 4 F 2.60 + + - - - - - - - - -
1.13 4 F 3.30 + + + + + - - - - - -
1.14 4 F 3.40 + + - + + - - + + + +
1.15 4 F 3.40 + + - + - - + - - - -
1.16 4 F 3.40 + + + + +++ - + - - - -
1.17 4 F 3.70 + + + - - - - - - - -
1.18 4 F 3.90 + + + +++ +++ + + + + + +
1.19 4 F 4.10 + + - + + - - - - - -
1.20 5 M 0.90 + + + - ++ - + - + - +
1.21 5 M 1.10 + + + - - - + - - - -
1.22 5 M 1.60 + + + +++ +++ + + - - + +
1.23 5 M 2.80 + - - - ++ - + - - - -
1.24 5 F 1.70 + + + + ++ - - - - - -
1.25 5 F 2.60 + + + - + - - - - - -
1.26 5 F 4.50 + + + + ++ - - - - - -
1.27 6 M 1.80 + + + + + - + - - + -
1.28 6 M 3.20 + + + - ++ + + - - - +
1.29 6 F 2.70 + + + ++ - - + - + - +
1.30 6 F 5.50 + + + +++ +++ + + - + - +
1.31 7 F 9.00 + + + + + + n.a. - - - -
1.32 n.a. M 2.40 + + + + + - + + - - +
1.33 n.a. M 2.70 - + + + - + + + + + +
1.34 n.a. M 3.10 + + + ++ ++ + - - - - -
n.a.–not available; F–female; M–male; S segment–reptareavirus S segment determined by RT-PCR; WB–Western Blot; Western Blot results graded according to signal
intensity:—(negative), + (weakly positive), ++ (moderately positive), +++ (strongly positive); ELISA–Enzyme linked immunosorbent assay.
https://doi.org/10.1371/journal.pone.0221863.t001
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3.895–4.665), whereas it was 5.647 (n = 17, 95%CI: 40260–4.994) for OScV-2 positive snakes
(t = -3.498, df: 65, p<0.05). None of the other population parameters showed any associations
with OScV-2 after controlling for age. OScV-1 and -2 detection showed poor to slight agree-
ment with the other tests (Cohen’s kappa < 0.2).
Table 2. Animals without BIBD included into the study (diagnosis based on the detection of intracytoplasmic inclusion bodies in blood cells, using blood smears).
Animal (number) Age (years) Sex Weight (kg) S segment WB ELISA
UGV-1 UGV-1 UHV NP UHV NP-C
UGV-2 S5-like TSMV-2 IgY IgM IgY IgM IgY IgM IgY IgM
2.01 2 M 0.9 - + + ++ + - + + + + +
2.02 2 M 1.5 - + + ++ +++ - + + - + +
2.03 2 F 1.3 - + + - + - - - - + +
2.04 3 M 1.2 - + + +++ ++ + + - - + +
2.05 3 M 1.3 + + + - - - + + - + +
2.06 3 M 1.7 - + + + +++ - - - - - -
2.07 3 M 1.8 - + + - ++ - + - - + -
2.08 3 F 2.2 - + + - - - + - - - -
2.09 4 M 2.1 + + + +++ ++ + - + - - -
2.10 4 M 2.7 + + + +++ +++ - + - + - -
2.11 4 M 3.3 + + + ++ ++ + - + + + +
2.12 4 F 3.7 - + + +++ +++ + + + - + +
2.13 4 F 3.8 - + + ++ ++ + + + + + +
2.14 4 F 5.8 - + + +++ ++ + + - - - -
2.15 4 F 6.8 - - - - - - - - - - -
2.16 5 M 2.2 + + + - - + - + - + +
2.17 5 M 2.5 - + + + + - - + + + +
2.18 5 F 5.0 + - + - + + - - - - -
2.19 5 F 5.3 - + - ++ + + + - - - -
2.20 5 F 5.3 - - - + - + - - - - -
2.21 5 F 5.5 - + + ++ - + - + - + +
2.22 5 F 5.7 - - + ++ - + + + + + +
2.23 5 F 6.1 - + + +++ + + - + - - -
2.24 6 M 2.5 + + + - - + - - - - -
2.25 6 M 3.4 + + + - - + + - - - -
2.26 6 M 3.5 - + + - + - - - - - -
2.27 6 F 3.1 - - - +++ +++ + + + + + -
2.28 6 F 5.6 - + + +++ +++ + - - - - -
2.29 7 M 3.3 + + - - ++ - - - - - -
2.30 7 M 4.0 - + + +++ + + - - - - -
2.31 7 F 5.0 + - + +++ +++ + - + - + -
2.32 7 F 7.0 - + + +++ +++ + - + + + +
2.33 7 F 7.5 - + + ++ ++ + + - - - +
2.34 7 F 10.0 - + + +++ +++ + - + + + +
2.35 8 M 3.4 - + + +++ + + - + + + +
2.36 8 F 7.0 - - - +++ ++ + + - - + +
n.a.–not available; F–female; M–male; S segment–reptareavirus S segment determined by RT-PCR; WB–Western Blot; Western Blot results graded according to signal
intensity:—(negative), + (weakly positive), ++ (moderately positive), +++ (strongly positive); ELISA–Enzyme linked immunosorbent assay.
https://doi.org/10.1371/journal.pone.0221863.t002
Antibodies in BIBD
PLOS ONE | https://doi.org/10.1371/journal.pone.0221863 September 9, 2019 6 / 28
Detection of reptarenavirus S segments in individual samples by RT-PCRs
Reptarenaviruses require both segments to make infectious particles; therefore, we applied spe-
cific RT-PCR for the above identified three S segments to all animals to recognise the reptare-
navirus infected, viraemic snakes. Of the 70 animals tested, we found 66 (94.3%) to exhibit
reptarenavirus viraemia. Thirty snakes (42.9%) carried all three S segments examined (UGV-/
S6-like, S5-like, and TSMV-2), and 32 (45.7%) carried two S segments. Of these, 21 snakes
(30%) showed a combination of the S5-like and TSMV-2 S segments, nine snakes (12.9%) had
the UGV-/S6-like and S5-like S segments, and two snakes (2.9%) had the UGV-/S6-like and
TSMV-2 S segments. Of the four snakes with a single S segment, we found the UGV-/S6-like S
segment in two, and the S5-like and TSMV-2 S segment in one snake each. The results are pre-
sented in detail in Table 1 and are summarised in Table 5.
We confirmed reptarenavirus viraemia in all BIBD-positive animals, and the majority (23/
34; 67.65%) of these snakes carried all three S segments examined (UGV-/S6-like, S5-like,
TSMV-2). Nine BIBD-positive snakes (26.47%) carried two S segments, and we detected only
the UGV-/S6-like S segment in the remaining two animals (5.88%; animals 1.07 and 1.23)
(Tables 1 and 5). The UGV-like S segment was present in BIBD-positive animals.
In BIBD-negative snakes (N = 36), we found all three viral S segments in seven snakes
(19.4%), whereas 23 animals (63.9%) carried two S segments, and two snakes (5.56%) had a
single S segment, one had the S5-like (animal 2.19) and the other the TSMV-2 (animal 2.22) S
segment. Four snakes (11.1%) were negative for each S segment and deemed to be reptarena-
virus-free (Tables 1 and 5).
Substantial agreement was identified between BIBD+ status and UGV-/S6-like S segment
RT-PCR results (Cohen’s κ = 0.6878). The agreement of the remaining RT-PCR tests with
BIBD is slight (S5-like κ = 0.1327, TMSV-2 κ = 0.1254, any segment detection κ = 0.183,
Table 5). Sensitivity and specificity calculations are included in Table 5, though the study was
not designed for such calculations.
We examined the associations of the RT-PCR results with population parameters (Table 6).
Female animals positive for the UGV-/S6-like S segment, as expected given the test agreement
with the presence of IB, have a significantly lower body weight (t = 2.99624882, df = 34,
Table 3. Results of inclusion body detection in blood cells (i.e. diagnosis of BIBD) against population parameters. Univariate analysis and stratification by sex.
Sex
(Row%)
(Col%)
Weight�
(95% CI)
N = 70
Age��(n)
(95% CI)
N = 67
M F All M F All M F All
BIBD - 17
(47.22%)
(50.00%)
19
(52.78%)
(52.78%)
36
(100.00%)
(51.43%)
2.238
(1.788–2.801)
4.912
(3.919–6.156)
3.389
(2.767–4.149)
4.588 (17)
(3.643–5.534)
5.211 (19)
(4.464–5.957)
4.917 (36)
(4.343–5.491)
BIBD
+
17
(50.00%)
(50.00%)
17
(50.00%)
(47.22%)
34
(100.00%)
(48.57%)
1.876
(1.532–2.297)
3.077
(2.373–3.991)
2.403
(2.010–2.873)
4.071 (14)
(3.305–4.838)
4.471 (17)
(3.922–5.019)
4.290 (31)
(3.854–4.726)
All 34
(48.57%)
(100.00%)
36
(51.36%)
(100.00%)
70
(100.00%)
(100.00%)
2.049
(1.770–2.372)
3.938
(3.287–4.719)
2.867
(2.497–3.293)
4.355 (31)
(3.759–4.950)
4.861 (36)
(4.395–5.327)
4.627 (67)
(4.260–4.994)
χ2 = 0.054, p = 0.816 t = 1.2365,
df = 32
p = 0.2253
t = 2.8801,
df = 34
p<0.01
t = 2.5748,
df = 68
p<0.05
t = 0.8785,
df = 29
p = 0.3869
t = 1.6494,
df = 34
p = 0.1083
t = 1.7226,
df = 65
p = 0.0897
�Kg, geometric mean
��Years
https://doi.org/10.1371/journal.pone.0221863.t003
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p<0.05). For male animals the difference in weight is not significant. There is no significant
difference in the age of UGV-/S6-like S segment RT-PCR-positive and -negative animals or in
their sex distribution. Multiple linear regression established that the age, sex and a positive
UGV-/S6-like S segment RT-PCR result are significantly associated with the weight of the ani-
mals, F (3,63) = 36.98, and they accounted for 62.06% of weight variability. The regression
equation is: Predicted Weight = -0.287 + 0.089 age + 0.235 sex—0.086 UGV-/S6-like indicating
that the weight of UGV-/S6-like positive animals is lower than the weight of negative snakes
after controlling for age and sex.
Fig 2. Association of BIBD, sex and body weight.
https://doi.org/10.1371/journal.pone.0221863.g002
Table 4. Multiple linear regression: Factors associated with weight (Kg log10) (n = 67).
Factors Adjusted b (95% CI) P-value
Sex (Female) 0.255 (0.178–0.333) < 0.001
Inclusion detection (positive) -0.107 (-0.185 –- 0.293 < 0.01
Age (years) 0.084 (0.058–0.110) < 0.001
Multiple linear regression (AdjR2 = 0.6374).
https://doi.org/10.1371/journal.pone.0221863.t004
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Table 5. Summary of RT-PCR results including test agreement and sensitivity/specificity with inclusion detection considered the gold standard.
BIBD Total Cohen’s κ Sensitivity
(95%CI)
Specificity
(95%CI)+ve -ve
UGV-2 +ve 33 10 43 κ = 0.688
(0.524–0.852)
97.06%
(93.10–100)%
72.22%
(61.73–82.71)%-ve 1 26 27
S5-like +ve 32 29 61 κ = 0.133
(-0.019–0.284)
94.12%
(88.61–99.63)%
19.44%
(10.17–28.72)%-ve 2 7 9
TSMV-2 +ve 24 30 54 κ = -0.125
(-0.320–0.069)
70.59
(59.91–81.26)%
16.67%
(7.94–25.40)%-ve 10 6 16
Any segment +ve 34 32 66 κ = 0.108
(0.005–0.212)
100% 11.11%
(3.75–18.47)%-ve 0 4 4
Total 34 36 70
https://doi.org/10.1371/journal.pone.0221863.t005
Table 6. RT-PCR results against population parameters, univariate analysis including stratification by sex.
Sex
(Row%)
(Col%)
Weight�
(95% CI)
N = 70
Age��(n)
(95% CI)
N = 67
M F Total M F Total M F Total
UGV
RT-PCR
-ve
10
(37.04%)
(29.41%)
17
(62.96%)
(47.22%)
27
(100.00%)
(38.57%)
2.090
(1.466–2.981)
4.901
(3.796–6.328)
3.575
(2.772–4.609)
4.333 (9)
(2.615–6.052)
5.118 (17)
(4.307–5.928)
4.846 (26)
(4.108–5.583)
UGV
RT-PCR
+ve
24
(55.81%)
(70.59%)
19
(44.19%)
(52.78%)
43
(100.00%)
(61.43%)
2.032
(1.720–2.400)
3.238506 2.544208
4.122274
2.497
(2.142–2.910)
4.355 (22)
(3.759–4.969)
4.632 (19)
(4.070–5.193)
4.488 (41)
(4.088–4.555)
χ2 = 2.341, p = 0.126 t = 0.1768,
df = 32
p = 0.8608
t = 2.4882, df = 34
p<0.05
t = 2.622,
df = 68
p<0.05
t = -0.046,
df = 29
p = 0.9633
t = 1.0597,
df = 34
p = 0.2968
t = 0.9485,
df = 65
p = 0.346
S5-like
RT-PCR
-ve
1
(11.11%)
(2.94%)
8
(88.89%)
(22.22%)
9
(100.00%)
(12.86%)
2.800 4.497
(2.937–6.884)
4.266
(2.900–6.275)
5.000 (1) 5.375 (8)
(4.039–6.711)
5.333 (9)
(4.180–6.486)
S5-like
RT-PCR
+ve
33
(54.10%)
(97.06%)
28
(45.90%)
(77.78%)
61
(100.00%
(87.14%)
2.030
(1.748–2.357)
3.792
(3.070–4.684)
2.704
(2.336–3.130)
4.333 (30)
(3.718–4.948)
4.714 (28)
(4.210–5.219)
4.517 (58)
(4.126–4.909)
χ2 = 5.8019, p<0.05 t = . . ., df = 32
p = . . .
t = 0.791, df = 34
p = 0.4344
t = 2.264,
df = 68
p<0.05
t = . . ., df = 29
p = . . . .
t = 1.2051,
df = 34
p = 0.2365
t = 1.528, df = 65
p = 0.131
TSMV-
2
RT-PCR
-ve
4
(25.00%)
(11.76%)
12
(75.00%)
(33.33%)
16
(100.00%)
(22.86%)
2.658
(1.734–4.074)
3.338
(2.301–4.842)
3.153
(2.383–4.172)
4.500 (4)
(1.453–7.547)
4.500 (12)
(3.622–5.378)
4.5 (16)
(3.722–5.278)
TSMV-
2
RT-PCR
+ve
30
(55.56%)
(88.24%)
24
(44.44%)
(66.67%)
54
(100.00%)
(77.14%)
1.979
(1.688–2.321)
4.278
(3.464–5.283)
2.788
(2.368–3.282)
4.333 (27)
(3.694–4.973)
5.042 (24)
(4.395–5.619)
4.667 (51)
(4.236–5.098)
χ2 = 4.6133, p<0.05 t = 1.3371,
df = 32
p = 0.1906
t = -1.3264, df = 34
p = 0.1936
t = 0.743,
df = 68
p = 0.460
t = 1.1885,
df = 29
P = 0.8518
t = -1.1170,
df = 34
p = 0.2718
t = -0.384,
df = 65
p = 0.702
Total 34
(48.57%)
(100.00%)
36
(51.43%)
(100.00%)
70
(100.00%)
(100.00%)
2.049
(1.770–2.372)
3.938
(3.287–719)
2.867
(2.497–3.293)
4.355 (31)
(3.759–4.950)
4.861 (36)
(4.395–5.329)
4.626 (67)
(4.260–4.994)
�Kg, geometric mean
��Mean Years
https://doi.org/10.1371/journal.pone.0221863.t006
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There is no significant difference in the age of S5-like S segment RT-PCR-positive and -neg-
ative animals but there are significantly more male positive animals (χ2 = 5.8019, p<0.05). The
animals’ weight is not significantly associated with a positive S5-like S segment RT-PCR result
after controlling for sex and age. There is no significant difference in the age of TMSV-2 S seg-
ment RT-PCR-positive and -negative animals. There are though significantly more male ani-
mals positive for the TMSV-2 S segment (χ2 = 4.435, p<0.05). The animals’ weight is not
significantly associated with a positive TMSV-2 S segment RT-PCR result after controlling for
sex and age.
Univariate analysis indicated that the number of S segments detected is not significantly
associated with the age of the animals (ANOVA: F(6,66) = 1.17, p = 0.333). Male animals had
significantly more S segments (mean = 2.559 [95%CI: 2.236–2.755]) than female animals
(mean = 1.972 [95%CI:1.664–2.280]), (p<0.01). Linear regression indicates that the number of
segments is negatively associated with the weight of the animals (F(1,68) = 8.83, R2 = 0.103,
Predicted weight = 0.696–0.106 number of segments, p<0.01). When the confounding effect
of sex was examined by stratifying for sex, no significant association was identified between
the number of S segments and the animals’ weight. There is a positive association between the
number of segments and the detection of IB in blood cells. The mean number of segments for
BIBD-positive animals is 2.618 (95%CI: 2.407–2.828) and for BIBD-negative animals 1.917
(95%CI: 1.632–2.201) (p<0.001).
Antibody response against reptarenavirus NP
So far, not much is known about the antibody response against reptarenaviruses in snakes. In
our first report on identification of reptarenaviruses in snakes with BIBD, we used an indirect
ELISA to indicate that there might be antibodies in some snakes with BIBD [7]. In a more
recent study, we generated tools for the detection of IgM and IgY class antibodies in boas, and,
using immunofluorescence and western blot, demonstrated that some BIBD-positive snakes
have antibodies against reptarenavirus NP [14].
Antibody detection by western blot (WB). We studied the plasma samples of the entire
collection using WB as the detection tool, and used concentrated UGV-1 virions as the anti-
gen. The main protein component of the virions is NP, which is why we interpret the signals
as anti-NP IgY and IgM. The signal intensities varied and we applied the following grading:
negative (–), weakly positive (+), moderately positive (++), and strongly positive (+++); the
WB result for each snake is included in Table 1. Among the 34 BIBD-positive snakes, we
found five (14.7%) negative for both anti-NP IgY and IgM, whereas 20 snakes (58.8%) had
both anti-NP IgM and IgY antibodies, and nine (26.5%) had either anti-NP IgY (N = 4) or
IgM (N = 5). Ten snakes were anti-NP IgY-negative and nine were anti-NP IgM-negative. The
36 BIBD-negative snakes included 22 (61.1%) anti-NP IgY- and IgM-positive snakes, eight
(22.2%) were positive for either anti-NP IgY (N = 3) or IgM (N = 5), six (16.7%) were negative
for both. Eleven snakes were anti-NP IgY-negative and nine anti-NP IgM negative. Within the
entire collection 11 snakes were negative for both anti-NP IgY and IgM antibodies. There are
no significant associations of WB results for NP IgY or IgM and any of the population
parameters.
The WB results for anti-NP IgY and IgM in relation to BIBD are summarised in Table 7.
The agreement of the WB results with BIBD is slight for anti-NP IgY (Cohen’s κ = 0.0294) and
poor for IgM (κ = 0.0000). As for the RT-PCR results we included indicative sensitivity and
specificity calculations. The sensitivity of the IgY WB in detecting BIBD is 70.6% (95%CI:
59.8%– 81.4%) and the specificity 32.4% (95%CI:21.2%– 64.3%). For IgM, the WB sensitivity
is 73.5% (95%CI:63.0% - 84.0%) and the specificity 26.5% (95%CI:16.0% - 37.0%). We
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examined the agreement of the BIBD status against the graded WB results using Cohen’s
weighted kappa(κ(w). For anti-NP IgY κ(w) is 0.0119 and for IgM κ(w) is 0.000 indicating
slight and poor agreement, respectively. We also examined the agreement between WB results
and RT-PCR results using Cohen’s kappa for binary WB results and weighted kappa for
graded WB results. In all cases the agreement was slight or poor. For anti-NP IgY WB results
in relation to UGV-2 RT-PCR Cohen’s κ = -0.195 and κ(w) = -0.074; in relation to S5-like
PT-PCR Cohen’s κ = 0.024 and κ(w) = 0.008; in relation to SMTV-2 RT-PCR Cohen’s κ =
0.088 and κ(w) = 0.03. For anti-NP IgM WB results in relation to UGV-2 RT-PCR Cohen’s κ
= 0.067 and κ(w) = -0.024; in relation to S5-like RT-PCR Cohen’s κ = 0.061 and κ(w) = 0.02;
in relation to SMTV-2 RT-PCR Cohen’s κ = 0.069 and κ(w) = 0.024.
Antibody detection by ELISA. Since the quantification of WB results is at best indicative
of the antibody titres, we decided to set up an ELISA test for the detection of anti-reptarena-
virus NP antibodies. We used purified UGV-1, recombinant UHV-1 NP, and the C-terminal
portion of UHV-1 NP (UHV-1 NP-C) as the antigens.
ELISA results as quantitative variables. We examined the ELISA results against the
BIBD status and the RT-PCR results using t-test. UGV-1 IgY ELISA OD values were signifi-
cantly higher for BIBD- (p<0.001) and UGV-2 RT-PCR- (p<0.05) negative animals, whereas
UGV-1 IgM ELISA OD values were significantly higher for BIBD-positive animals (p<0.05).
UHV-1 NP IgY ELISA OD values were significantly higher for BIBD- (p<0.001) and UGV-2
RT-PCR- (p<0.01) negative animals, UHV-1 NP-C IgY ELISA OD values were significantly
higher for BIBD (p<0.01) and UGV-2 RT-PCR (p<0.01) negative animals, and UHV-1 NP-C
IgM ELISA OD values were significantly higher for BIBD- (p<0.05) and UGV-2 RT-PCR-
(p<0.01) negative animals and for SMTV-2 RT-PCR-positive animals (p<0.05). Table 8 pro-
vides the detailed results of the analysis.
ELISA results for IgY and IgM from all the tests were analysed against population parame-
ters and the other tests. At univariate level we used Analysis of Variance (ANOVA) to examine
associations between age and antibody titres. UGV-1 IgY ELISA titres were the only ones sig-
nificantly associated with age (F (6,59) = 3.52, p<0.01). Linear regression established that
weight was significantly associated with ELISA titres for UGV-1 IgY and UGV-1 IgM (Regres-
sion equations UGV-1 IgY: F(1.67) = 32.4, R2 = 0.326, Predicted UGV-1 IgY = -1.245 + 1.556
weight; Predicted UGV-1 IgM: F(1.67) = 4.9 = -0.217–0.188 weight). There was no significant
association between any of the ELISA test results and the animals’ sex. The results of the uni-
variate analysis are presented in Table 9.
Using multivariable linear regression, we examined the associations of UGV-1 IgY and IgM
with BIBD, weight and age. We established that both age and BIBD+ status were significantly
associated with UGV-1 IgY antibody titres, F(2,63) = 16.94, and they accounted for 32.90% of
antibody variability (p<0.001). The regression equation is: Predicted UGV- IgY OD(log10) =
-1.147 + 0.181 age—0.4812 BIBD+. Fig 3A illustrates this association, with BIBD-negative
Table 7. Results of the detection of IgY and IgM plasma antibodies against UGV-1 virions using WB in comparison to the diseases status (BIBD-positive or–nega-
tive, based on the presence of cytoplasmic IB in blood cells.
Western blotting BIBD Cohen’s κ Sensitivity
(95%CI)
Specificity
(95%CI)+ve -ve Total
WB UGV1 IgY +ve 24 25 49 κ = 0.011
(-0.195–0.218)
70.59%
(59.91–81.26)%
30.56%
(19.76–41.35)%-ve 10 11 21
WB UGV1 IgM +ve 25 27 52 κ = -0.015
(-0.222–0.193)
73.53%
(63.19–83.86)%
25.00%
(14.86–35.14)%-ve 9 9 18
Total 34 36 70
https://doi.org/10.1371/journal.pone.0221863.t007
Antibodies in BIBD
PLOS ONE | https://doi.org/10.1371/journal.pone.0221863 September 9, 2019 11 / 28
Table 8. ELISA results against RT-PCR and IB detection.
ELISA
Alternative test
UGV1 IgY� (n)
(95%CI)
UGV1 IgM� GM (n)
(95%CI)
UHV1 NP IgY� (n)
(95%CI)
UHV1 NP IgM� (n)
(95%CI)
UHV-1 NP-C IgY� (n)
(95%CI)
UHV-1 NP-C IgM� (n)
(95%CI)
BIBD +ve 0.155 (33)
(0.095–0.252)
0.561 (33)
(0.479–0.657)
0.156 (34)
(0.114–0.213)
0.250 (34)
(0.202–0.308)
0.251 (34)
(0.191–0.329)
0.290 (34)
(0.241–0.351)
BIBD -ve 0.553 (36)
(0.337–0.906)
0.448 (36)
(0.399–0.503)
0.306 (36)
(0.244–0.385)
0.255 (36)
(0.199–0.327)
0.556 (36)
(0.452–0.682)
0.379 (36)
(0.339–0.422)
t-test t = 3.7246, df = 67
P<0.001
t = -2.3586, df = 67
p<0.05
t = 3.5899, df = 68
p<0.001
t = 0.1294, df = 68
p = 0.903
t = 4.771, df = 68
p<0.001
t = 2.5368, df = 68
p<0.05
UGV-2 RT-PCR +ve 0.209 (42)
(0.133–0.329)
0.464 (42)
(0.398–0.540)
0.173 (43)
(0.132–0.226)
0.254 (43)
(0.214–0.301)
0.282 (43)
(0.221–0.361)
0.296 (43)
(0.254–0.344)
UGV-2 PR-PCR -ve 0.530 (27)
(0.288–0.975)
0.464 (27)
(0.458–0.596)
0.326 (27)
(0.251–0.123)
0.249 (27)
(0.179–0.346)
0.598 (27)
(0.480–0.744)
0.402 (27)
(0.356–0.454)
t-test t = 2.5322, df = 67
p<0.05
t = -1.181, df = 67
p = 0.2118
t = 3.2325, df = 68
p<0.01
t = -0.1199, df = 68
p = 0.9049
t = 4.2732, df = 68
p<0.001
t = 2.9145, df = 68
p<0.01
S5-like RT-PCR +ve 0.262 (60)
(0.180–0.382)
0.495 (60)
(0.445–0.551)
0.207 (61)
(0.168–0.256)
0.251 (61)
(0.210–0.301)
0.353 (61)
(0.292–0.427)
0.333 (61)
(0.295–0.375)
S5-like PT-PCR -ve 0.745 (9)
(0.171–0.324)
0.522 (9)
(0.378–0.718)
0.339 (9)
(0.156–0.733)
0.260 (9)
(0.197–0.344)
0.592 (9)
(0.263–1.330)
0.335 (9)
(0.295–0.375)
t-test t = 1.9239, df = 67
p = 0.0586
t = 0.3602, df = 67
p = 0.7199
t = 1.6353, df = 68
p = 0.1068
t = 0.1522, df = 68
p = 0.8795
t = 1.8398, df = 68
p = 0.0702
t = 0.041, df = 68
p = 0.9674
SMTV-2 RT-PCR +ve 0.334 (53)
(0.220–0.508)
0.506 (53)
(0.452–0.567)
0.235 (54)
(0.192–0.289)
0.259 (54)
(0.213–0.315)
0.407 (54)
(0.334–0.495)
0.359 (54)
(0.320–0.402)
SMTV-2 PT-PCR -ve 0.212 (16)
(0.088–0.507)
0.475 (16)
(0.383–0.589)
0.178 (16)
(0.098–0.546)
0.230 (16)
(0.179–0.296)
0.292 (16)
(0.171–0.500)
0.258 (16)
(0.198–0.337)
t-test t = -1.0373, df = 67
p = 0.3033
t = -0.5349, df = 67
p = 0.5945
t = -1.1503, df = 68
p = 0.2541
t = -0.6136, df = 68
p = 0.5415
t = -1.4677, df = 68
p = 0.1468
t = -2.6477, df = 68
p<0.05
Total 0.301 (69)
(0.207–0.436)
0.499 (69)
(0.452–0.550)
0.221 (70)
(0.180–0.270)
0.252 (70)
(0.215–0.296)
0.377 (70)
(0.312–0.456)
0.333 (70)
(0.299–0.371)
�Optical density geometric mean
https://doi.org/10.1371/journal.pone.0221863.t008
Table 9. Associations between ELISA results and population parameters, univariate analysis.
Sex
(95%CI)
Weight
Linear regression results
Age
ANOVA results
OD geometric
mean
Male Female All p value F
R2
Coef Adjusted b ((95%
CI)
p value F p value
UGV-1
RT-PCR IgY
0.208
(0.122–
0.352)
0.422
(0.251–
0.710)
0.301
(0.207–
0.436)
t = -1.9407,
df = 67
p = 0.0565
(1.67) =
32.4
0.316
-0.245
(-1.532–
0.959)
1.556
(1.010–2.102)
p<0.0001 (6,59) =
3.52
p<0.01
UGV1
RT-PCR IgM
0.540
(0.472–
0.618)
0.462
(0.400–
0.534)
0.499
(0.452–
0.550)
t = 1.6002,
df = 67
p = 0.1143
(1.67) =
4.90
0.0542
-0.217
(-0.304 -
-0.131)
-0.188
(-0.357 –-0.185)
P<0.05 (6.59) =
1.26
p = 0.2876
UHV-1 NP
RT-PCR IgY
0.242
(0.196–
0.299)
0.202
(0.142–
0.287)
0.221
(0.180–
0.270)
t = 0.8919,
df = 68
p = 0.3756
(1.68) =
0.04
-0.141
-0.673
(-0.858–
0.487)
0.036
(-0.319–0.391)
p = 0.84 (6,60) = 1 p = 0.4365
UHV-1 NP
RT-PCR IgM
0.265
(0.228–
0.308)
0.241
(0.181–
0.320)
0.252
(0.215–
0.296)
t = 0.5993,
df = 68
p = 0.5510
(1,68) =
0.43
-0.0083
-0.556
(-0.701 -
-0.411)
-0.092
(-0.369–0.186)
p = 0.513 (6,60) =
0.71
p = 0.6398
UHV-1 NPC
RT-PCR IgY
0.382
(0.298–
0.489)
0.373
(0.276–
0.504)
0.377
(0.312–
0.456)
t = 1.1234,
df = 68
p = 0.9021
(1,68) =
0.86
-0.0021
-0.494
(-0.666
–-0.321)
0.153
(-0.178–0.485)
p = 0.358 (6,60) =
1.45
p = 0.2093
UHV-1 NP-C
RT-PCR IgM
0.335
(0.294–
0.381)
0.331
(0.277–
0.396)
0.333
(0 .299–
0.371)
t = 0.1052,
df = 68
p = 0.9165
(1,68) =
0.71
-0.0041
-0.514
(-0.312
–-0.416)
0.080
(-0.108–0.268)
p = 0.401 (6,60) =
0.77
p = 0.598
https://doi.org/10.1371/journal.pone.0221863.t009
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animals demonstrating higher antibody titres than BIBD-positive ones. A similar model when
fitted for UGV-1 IgM did not provide significant results. We include the graphic representa-
tion (Fig 3B) as the result may indicate an interesting trend of UGV-1 IgM remaining at higher
levels for BIBD-positive animals because of continuous exposure from circulating virus while
in BIBD-negative snakes, lack of such exposure may lead to UGV-1 IgM reduction in older
animals. (Fig 3A–3F) demonstrates the association of all the ELISA test results with age and IB
detection.
Multivariable linear regression also established that age, sex and plasma UGV1 IgY were
significantly associated (p<0.0001) with the weight of the animals, F(3,62) = 38.24 and they
accounted for 63.22% of weight variability. The regression equation is: Predicted Weight =
0.079 + 0.075 age + 0.195 sex—0.096 UGV1 IgY OD. Fig 4 demonstrates this association sepa-
rately for male and female animals. To establish linearity in this and all previous cases, we
checked the residuals for normalcy using Shapiro-Wilk test and examined a residual versus fit-
ted values plot.
We then investigated the potential association between the number of S segments found
and the antibody response. Of the 23 BIBD-positive snakes in which all three viral S segments
were detected, six (26.09%) were positive for anti-UGV IgY and 14 (63.64%) for anti-UGV
IgM antibodies, four (18.18%) carried both IgY and IgM, and seven (31.82%) were negative
for either antibodies. Among the nine snakes with two S segments were two (22.22%) that
exhibited anti-UGV IgY antibodies, and three (33.33%) were positive for anti-UGV IgM anti-
bodies. The two IgY-positive snakes also carried anti-NP IgM antibodies (22.22%); six snakes
(66.67%) were negative for either antibodies. Both BIBD-positive snakes in which only the
UGV-/S6-like S segment was detected exhibited an anti-NP IgM response; one also carried
Fig 3. Associations of ELISA test results with age and BIBD status. A) UGV1 IgY, B) UGV1 IgM, C) UHV1 NP IgY, D) UHV1 NP IgM, E) UHV1 NPC IgY, F)
UHV1 NPC IgM. The red lines indicate the ELISA cut-off point.
https://doi.org/10.1371/journal.pone.0221863.g003
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anti-NP IgY antibodies. All seven BIBD-negative animals tested positive for three viral S seg-
ments carried UGV-specific antibodies, five (71.43%) were IgY-positive, and three (42.86%)
IgM-positive, one snake (14.29%) was positive for both Igs. Of the animals positive for two S
segments (n = 23), the majority carried IgY (n = 14; 60.87%), nine (39.13%) were IgM-positive,
and five (21.74%) were positive for both antibodies; five animals (21.74%) did not exhibit an
antibody response. Both snakes in which a single viral S segment was detected exhibited both
an IgY and an IgM response. Of the four RT-PCR negative animals, two (50%) showed a com-
bined IgY and IgM response, one only had IgY antibodies, and one did not exhibit an anti-
reptarenavirus response. There is no significant association between the number of segments
and any of the ELISA results.
ELISA cut-off points. The background corrected raw ELISA data with cut-off values are
presented in Fig 5. We tested the BIBD-positive snakes for the presence of anti-UGV-1 IgY
and IgM antibodies and found nine (26.5%) IgY positives and 19 (57.58%) IgM positives of
which seven (21.21%) were also IgY-positive. Thirteen animals (39.39%) did not exhibit any
anti-UGV-1 antibodies (Table 10). Of the 36 BIBD-negative snakes 24 (66.67%) had anti-
UGV-1 IgY and 16 (44.44%) anti-UGV-1 IgM antibodies, 10 animals (27.78%) showed both
IgY and IgM; six snakes (16.67%) did not exhibit any anti-UGV-1 antibodies (Table 11).
Fig 4. Association of body weight and UGV-1 IgY antibodies in female and male snakes.
https://doi.org/10.1371/journal.pone.0221863.g004
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Within the group of BIBD-positive snakes were six (17.65%) that carried anti-UHV-1-NP
IgY and seven (20.59%) positive for IgM. Four snakes (11.76%) carried both antibodies and 25
(73.53%) did not exhibit any anti-UHV-1 antibodies. The examination of UHV-1-NP antibod-
ies in the BIBD-negative group identified 17 snakes (47.22%) with IgY and nine (25%) with
IgM antibodies. A combination of IgY and IgM was detected in eight snakes (22.22%), whereas
18 (50%) were negative for both anti-UHV-1-NP antibodies. Of the BIBD-positives snakes
seven (20.59%) had anti-UHV-1-NP-C IgY and 10 (29.41%) IgM antibodies. Both antibodies
were found in five snakes (14.71%) and 22 (64.71%) were negative for IgY and IgM. Among
the BIBD-negative animals 19 (52.78%) carried IgY and 17 (47.22%) were positive for IgM of
which 16 (44.44%) also exhibited an IgY antibody response; 16 snakes (44.44%) did not carry
any anti-UHV-1-NP-C antibodies.
We examined the agreement of the different ELISA tests with the BIBD status using
Cohen’s kappa (Table 11). Because significantly more BIBD-positive animals were testing neg-
ative for IgY (above the cut-off point, see Table 1), and because the measured OD values in
ELISA were lower in BIBD-positive than in BIBD-negative animals we calculated the test
agreement, using Cohen’s kappa, considering negative ELISA results equivalent to positive
BIBD ones. We reversed thus the UGV-1 IgY ELISA results (positive to negative) which led to
a moderate agreement with BIBD (κ = 0.429). The same applied to UHV-1 NP IgY ELISA (κ =
0.293) and UHV NP-C IgY (κ = 0.319) which showed fair agreement with BIBD. All IgM
ELISA results show slight or poor agreement with BIBD (UGV-1 IgM, κ = 0.131; UHV-1 NP
IgM, κ = -0.045; UHV1 NP-C IgM, κ = -0.179). Results are summarised in Tables 12 and 13
including the agreement between ELISA results and RT-PCR. All results indicate poor to fair
agreement between tests. 95% confidence intervals were calculated for Cohen’s kappa and fur-
ther confirm the lack of agreement between tests [42].
Fig 5. ELISA results including cut-off values for UGV-1 IgY and IgM, UHV NP IgY and IgM, UHV NP-C IgY and IgM antibodies in BIBD-positive and BIBD-
negative snakes.
https://doi.org/10.1371/journal.pone.0221863.g005
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Using univariate analysis, we examined the ELISA test results based on the cut-off points
for associations with population parameters. There is no significant association between ani-
mal sex and any of the ELISA results. The presence of UGV-IgY is significantly associated with
weight. The geometric mean (GM) weight of UGV-IgY-positive animals (n = 34) is 3.809 kg
(95% CI: 3.159–4.594) while for UGV-IgY-negative animals (n = 36) the geometric mean
weight is 2.193 kg (95%CI: 1.858–2.589kg, p<0.0001). This association remained significant
after stratification for sex for both male and female animals (Male: UGV-IgY positive animals
(n = 14) GM = 2.448 kg [95%CI: 1.995–3.004], UGV-IgY negative animals (n = 20) GM =
1.809 kg [95%CI: 1.484–2.206], p<0.05; Female: UGV-IgY positive animals (n = 16) GM =
5.192 kg [95%CI: 4.283–6.293 ], UGV-IgY negative animals (n = 20) GM = 2.788 kg [95%CI:
2.167–3.588], p<0.001). A significant association was also identified between UGV-IgY and
the animals’ age. UGV-IgY-positive animals are significantly older than negative animals
(p<0.001). The average age is 5.313 years (95%CI: 4.783–5.842) and 4 years (95%CI: 3.567–
4.329) for UGV-IgY positive animals (n = 32) and negative animals (n = 35) respectively. After
stratifying for sex, the association remained significant for female animals (UGV1 IgY positive
animals (n = 20) mean age = 5.5 years) [95%CI: 4.865–6.135]; UGV-IgY negative (n = 16)
mean age = 4.063 years [95%CI: 3.568–4.557], p<0.005). No other association was identified
between any of the ELISA results based on the cut-off point and population parameters. All
the results are presented in Tables 14 and 15.
Table 10. Results obtained from the examination of UGV-2, S5-like and TSMV-2 specific S-segments by RT-PCR and UGV-1, UHV-1 NP and UHV-1 NP-C specific
IgY and IgM antibodies by ELISA—Animals with BIBD.
RT-PCR UGV-1 UHV-1 NP UHV-1 NP-C
IgY IgM n = 33
tested
IgY and IgM
n = 33 tested
IgY IgM IgY and
IgM
IgY IgM IgY and
IgM
Positive
34/34 (100%)
Pos
9/34 (26.47%)
Pos
19/33
(57.58%)
Pos
7/33 (21.21%)
Pos 6/34
(17.65%)
Pos 7/34
(20.59%)
Pos
4/34
(11.76%)
Pos 7/34
(20.59%)
Pos 10/34
(29.41%)
Pos
5/34
(14.71%)
Neg 25/34
(73.53%)
Neg
14/33
(42.42%)
Neg
13/33 (39.39%)
Neg 28/34
(82.35%)
Neg 27/34
(79.41%)
Neg
25/34
(73.53%)
Neg 27/34
(79.41%)
Neg 24/34
(70.59%)
Neg
22/34
(64.71%)
3 Segments 23/34
(67.65%)
Pos
6/23 (26.09%)
Pos
14/22
(63.64%)
Pos
4/22 (18.18%)
Pos 2/23
(8.7%)
Pos 4/23
(17.39%)
Pos
1/23
(4.35%)
Pos 3/23
(13.04%)
Pos 7/23
(30.43%)
Pos
2/23
(8.7%)
Neg 17/23
(73.91%)
Neg
8/22
(36.36%)
Neg
7/22 (31.82%)
Neg 21/23
(91.3%)
Neg 19/23
(82.61%)
Neg
18/23
(78.26%)
Neg 20/23
(86.96%)
Neg 16/23
(69.57%)
Neg
15/23
(65.22%)
2 Segments
9/34 (26.47%)
Pos
2/9 (22.22%)
Pos
3/9
(33.33%)
Pos
2/9
(22.22%)
Pos 3/9
(33.33%)
Pos 2/9
(22.22%)
Pos
2/9
(22.22%)
Pos 3/9
(33.33%)
Pos 2/9
(22.22%)
Pos
2/9
(22.22%)
Neg
7/9 (77.78%)
Neg
6/9
(66.67%)
Neg
6/9
(66.67%)
Neg 6/9
(66.67%)
Neg 7/9
(77.78%)
Neg
6/9
(66.67%)
Neg 6/9
(66.67%)
Neg 7/9
(77.78%)
Neg
6/9
(66.67%)
1 Segment
2/34 (5.88%)
Pos
1/2
(50%)
Pos
2/2
(100%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Neg
1/2
(50%)
Neg
0/2
(0%)
Neg
0/2
(0%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Pos–positive; Neg—negative
https://doi.org/10.1371/journal.pone.0221863.t010
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Discussion
In this study, we investigated the association between BIBD, pathogen detection, population
parameters and serological findings in a cohort of snakes from one breeding colony. As our
previous studies had implied an association between BIBD and low antibody levels [7,14], the
main focus of this study was on a potential link between anti-reptarenavirus antibody levels
and BIBD. We hypothesised that some reptarenavirus S segments can be found more fre-
quently in snakes with BIBD, and that healthy and diseased snakes would show different S seg-
ment profiles. We examined a panel of 70 blood samples, evenly distributed by sex, collected
on the same day from the entire animal cohort. Because snakes are poikilotherms, we consid-
ered minimising the environmental influence on the immune response to be essential. There-
fore, the study was restricted to a single breeding colony where animals are kept under
virtually the same husbandry conditions with regards to moisture, light, feeding regime and
Table 11. Results obtained from the examination of UGV-2, S5-like and TSMV-2 specific S-segments by RT-PCR and UGV-1, UHV-1 NP and UHV-1 NP-C specific
IgY and IgM antibodies by ELISA—Animals without BIBD.
RT-PCR UGV-1 UHV-1 NP UHV-1 NP-C
IgY IgM IgY and IgM IgY IgM IgY and IgM IgY IgM IgY and IgM
Positive/
Negative 36/36
(100%)
Pos 24/36
(66.67%)
Pos
16/36
(44.44%)
Pos
10/36
(27.78%)
Pos 17/36
(47.22%)
Pos 9/36 (25%) Pos
8/36
(22.22%)
Pos 19/36
(52.78%)
Pos 17/36
(47.22%)
Pos
16/36
(44.44%)
Neg 12/36
(33.33%)
Neg
20/36
(55.56%)
Neg
6/36
(16.67%)
Neg 19/36
(52.78%)
Neg 27/36
(75%)
Neg
18/36
(50%)
Neg 17/36
(47.22%)
Neg 19/36
(52.78%)
Neg
16/36
(44.44%)
Positive 32/36
(88.89%)
Pos
21/32 (65.63%)
Pos
14/32
(43.75%)
Pos
8/32
(25.00%)
Pos
16/32 (50%)
Pos
9/32 (28.13%)
Pos
8/32
(25.00%)
Pos
17/32 (53.13%)
Pos
16/32 (50%)
Pos
15/32
(46.88%)
Neg
11/32 (34.38%)
Neg
18/32
(56.25%)
Neg
5/32
(15.63%)
Neg
16/32 (50%)
Neg 23/32
(71.88%)
Neg
15/32
(46.88%)
Neg
15/32 (46.88%)
Neg
16/32 (50%)
Neg
14/32
(43.75%)
3 Segments 7/32
(21.88%)
Pos
5/7 (71.43%)
Pos
3/7
(42.86%)
Pos
1/7
(14.29%)
Pos
4/7 (57.14%)
Pos
2/7 (28.57%)
Pos
1/7
(14.29%)
Pos
3/7 (42.86%)
Pos
3/7 (42.86%)
Pos
3/7
(42.86%)
Neg
2/7
(28.57%)
Neg
4/7
(57.14%)
Neg
0/7
(0%)
Neg
3/7 (42.86%)
Neg
5/7 (71.43%)
Neg
2/7
(28.57%)
Neg
4/7 (57.14%)
Neg
4/7 (57.14%)
Neg
4/7
(57.14%)
2 Segments 23/32
(71.88%)
Pos
14/23 (60.87%)
Pos
9/23
(39.13%)
Pos
5/23
(21.74%)
Pos
11/23 (47.83%)
Pos
6/23 (26.09%)
Pos
6/23
(26.09%)
Pos
13/23 (56.52%)
Pos 12/23
(52.17%)
Pos
11/23
(47.83%)
Neg
9/23 (39.13%)
Neg
14/23
(60.87%)
Neg
5/23
(21.74%)
Neg 12/23
(52.17%)
Neg 17/23
(73.91%)
Neg
12/23
(52.17%)
Neg 10/23
(43.48%)
Neg
11/23 (47.83%)
Neg
9/23
(39.13%)
1 Segment 2/32
(6.25%)
Pos
2/2
(100%)
Pos
2/2
(100%)
Pos
2/2
(100%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Pos
1/2
(50%)
Neg
0/2
(0%)
Neg
0/2
(0%)
Neg
0/2
(0%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Neg
1/2
(50%)
Negative 4/36
(11.11%)
Pos
3/4
(75%)
Pos
2/4
(50%)
Pos
2/4
(50%)
Pos
1/4
(25%)
Pos
0/4
(0%)
Pos
0/4
(0%)
Pos
2/4
(50%)
Pos
1/4
(25%)
Pos
1/4
(25%)
Neg
1/4
(25%)
Neg
2/4
(50%)
Neg
1/4
(25%)
Neg
3/4
(75%)
Neg
4/4 (100%)
Neg
3/4
(75%)
Neg
2/4
(50%)
Neg
3/4
(75%)
Neg
2/4
(50%)
Pos–positive; Neg—negative
https://doi.org/10.1371/journal.pone.0221863.t011
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temperature, except that male snakes are kept at 2–5˚C lower temperatures than females to
increase reproductive activity.
We started by dividing the sample panel in BIBD positives and negatives based on the
detection of IBs in blood cells, using blood smears stained under quality controlled conditions.
We used the presence of IBs in combination with confirmed reptarenavirus infection as the
diagnostic criteria for BIBD, since we consider it likely that the presence of reptarenavirus NP
in the form of IBs in cells will eventually result in clinical signs and death of affected animals
[1,12,13]. The examination of population parameters in our study did not show an association
of age and the presence of IB, suggesting that the time and duration of the infection would not
Table 12. ELISA results based on the cut-off points against inclusion detection including test agreement and sensitivity/Specificity.
ELISA test BIBD Cohen’s κ
(95%CI)
Sensitivity Specificity
+ve -ve Total
UGV1 IgY +ve 25 11 34 κ = 0.429
(0.213–0.645)
73.53%
(63.19–83.86) %
69.44%
(58.65–80.24) %-ve 9 25 36
UGV1 IgM� +ve 14 20 34 κ = -0.131
(-0.360–0.097)
42.42%
(30.76–54.09) %
44.44%
(32.72–56.17) %-ve 19 16 35
UHV1 NP IgY +ve 28 19 47 κ = 0.293
(0.075–0.510)
82.35%
(73.42–91.28) %
47.22%
(35.53–58.92) %-ve 6 17 23
UHV1 NP IgM +ve 7 9 16 κ = 0.043
(-0.145–0.232)
79.41%
(69.94–88.88) %
25.00%
(14.86–35.14) %-ve 24 27 54
UHV1 NP-C IgY +ve 27 17 44 κ = 0.319
(0.100–0.539)
79.41%
(69.94–88.88) %
52.78%
(41.08–64.47) %-ve 7 19 26
UHV1 NP-C IgM +ve 24 19 43 κ = 0.177
(-0.051–0.405)
70.59%
(59.91–81.26) %
47.22%
(35.53–58.92) %-ve 10 17 27
Total 34 36 70
�missing value
https://doi.org/10.1371/journal.pone.0221863.t012
Table 13. Agreements of ELISA tests with IB detection and RT-PCR.
ELISA test BIBD UGV-2 S5-like SMTV-2
+ve -ve Cohen’s κ +ve -ve Cohen’s κ
(95%CI)
+ve -ve Cohen’s κ +ve -ve Cohen’s κ Total
UGV1 IgY +ve 25 11 κ = 0.429
(0.213–0.645)
28 8 0.339
(0.119–0.558)
34 2 0.153
(-0.009–0.316)
26 10 -0.103
(-0.307–0.102)
36
-ve 9 25 15 19 27 7 28 6 34
UGV1 IgM� +ve 14 20 κ = -0.131
(-0.360–0.097)
21 13 0.018
(-0.209–0.244)
30 4 0.025
(-0.134–0.184)
25 9 -0.064
(-0.267–0.139)
34
-ve 19 16 21 14 30 5 28 7 35
UHV1 NP IgY +ve 28 19 κ = 0.293
(0.075–0.510)
33 14 0.256
(0.018–0.494)
42 5 0.080
(-0.129–00289)
35 12 -0.088
(-0.307–0.131)
47
-ve 6 17 10 13 19 4 19 4 23
UHV1 NP IgM +ve 27 27 κ = 0.043
(-0.145–0.232)
35 19 0.119
(-0.103–0.342)
47 7 -0.005
(-0.220–0.209)
40 14 -0.134
(-0.333–0.064)
54
-ve 7 9 8 8 14 2 14 2 16
UHV1 NP-C IgY +ve 27 17 κ = 0.319
(0.100–0.539)
33 11 0.363
(0.133–0.592)
40 4 0.117
(-0.083–0.318)
33 11 -0.063
(-0.284–0.159)
44
-ve 7 19 10 16 21 5 21 5 26
UHV1 NP-C IgM +ve 24 19 κ = 0.177
(-0.051–0.405)
31 12 0.276
(0.037–0.515)
37 6 -0.032
(-0.209–0.144)
30 13 -0.207
(-0.400 –-0.014)
43
-ve 10 17 12 15 24 3 24 3 27
Total 34 36 43 27 61 9 54 16 70
�missing value
https://doi.org/10.1371/journal.pone.0221863.t013
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be a factor in the development of BIBD, though this is highly speculative as data on, for exam-
ple, the introduction of individual animals was not available. Also, a dependency of sex and
BIBD could not be shown, but we could demonstrate a statistically significant association
between BIBD and reduced body weight in female snakes. While this may reflect the low num-
ber of snakes included in the study, it might also be indicative of metabolic or behavioural
changes in the infected snakes. Since reptarenavirus replication is temperature sensitive [43],
one could also speculate that the viruses replicate more efficiently in female snakes as these are
housed at slightly higher temperatures. Further studies on the optimal reptarenavirus replica-
tion temperature would be required to address this hypothesis.
By NGS and de novo genome assembly, we identified two pairs of hartmanivirus L and S
segments, several reptarenavirus L segments but only a single reptarenavirus S segment
(UGV-like) from the RNA of a BIBD-positive blood pool [10]. Interestingly, reads matching
reptarenaviruses were clearly less abundant in the RNA sample extracted from the BIBD-nega-
tive blood. This finding could indicate higher replication or more intense viraemia in the
Table 14. IgY ELISA cut-off point results against population parameters, univariate analysis including stratification by sex.
Sex
(Row%)
(Col%)
Weight�
(95% CI)
N = 70
Age��(n)
(95% CI)
N = 67
M F Total M F Total M F Total
UGV- 1
IgY ELISA
-ve
20
(55.56%)
(58.82%)
16
(44.44%)
(44.44%)
36
(100.00%)
(51.43%)
1.809
(1.484–2.206)
2.788
(2.167–3.588)
2.193
(1.858–2.589)
3.947 (19)
(3.220–4.674)
4.063 (16)
(3.568–4.557)
4.000 (35)
(3.567–4.329)
UGV-1
IgY ELISA
+ve
14
(41.18%)
(41.18%)
20
(58.82%)
(55.86%)
34
(100.00%)
(48.57%)
2.448
(1.995–3.004)
5.192
(4.283–6.293)
3.809
(3.159–4.594)
5.000 (12)
(3.951–6.049)
5.500 (20)
(4.865–6.135)
5.313 (32)
(4.783–5.842)
χ2 = 1.4473, p = 0.229 t = -2.1855,
df = 32
p<0.05
t = -4.2166,
df = 34
p<0.001
t = -4.480,
df = 68
p<0.0001
t = -1.8251,
df = 29
p = 0.0783
t = -3.609, df = 34
p<0.005
t = -3.935,
df = 65
p<0.001
UHV-1 NP
IgY ELISA
-ve
23
(48.94%)
(67.65%)
24
(51.06%)
(66.67%)
47
(100.00%)
(67.14%)
2.005
(1.666–2.412)
3.711
(2.930–4.701)
2.745
(2.313–3.259)
4.500 (22)
(3.819–5.181)
4.750 (24)
(4.163–5.337)
4.630 (46)
(3.865–5.373)
UHV-1 NP
IgY ELISA
+ve
11
(47.83%)
(32.35%)
12
(52.17%)
(33.33%)
23
(100.00%)
(32.86%)
2.145
(1.622–2.837)
4.436
(3.268–6.020)
3.134
(2.442–4.020)
4.000 (9)
(2.562–5.438)
5.083 (12)
(4.207–5.959)
4.619 (21)
(3.865–5.374)
χ2 = 0.076, p = 0.930 t = -0.4349,
df = 32
p = 0.6667
t = -0.9422,
df = 34
p = 0.3527
t = -0.894,
df = 68
p = 0.3746
t = 0.773, df = 29
p = 0.4458
t = -0.6797,
df = 34
p = 0.5013
t = 0.285,
df = 65
p = 9774
UHV-1
NP-C
IgY ELISA
-ve
21
(47.73%)
(61.76%)
23
(52.27%)
(63.89%)
44
(100.00%)
(62.86%)
2.121
(1.745–2.576)
3.861
(3.086–4.831)
2.901
(2.446–3.440)
4.526 (19)
(3.784–5.269)
4.739 (23)
(4.265–5.213)
4.643 (42)
(4.237–5.049)
UHV-1
NP-C
IgY ELISA
+ve
13
(50.00%)
(38.24%)
13
(50.00%)
(36.11%)
26
(100.00%)
(37.14%)
1.938
(1.508–2.492)
4.079
(2.870–5.798)
2.812
(2.186–3.618)
4.083 (12)
(2.951–5.215)
5.077 (13)
(3.989–6.165)
4.600 (25)
(3.846–5.354)
χ2 = 0.0338, p = 0.854 t = 0.6009,
df = 32
p = 0.5521
t = -0.2922,
df = 34
p = 0.7718
t = 0.2146,
df = 68
p = 0.831
t = 0.7342,
df = 29
p = 0.4687
t = -0.7021,
df = 34
p = 0.4874
t = 0.112,
df = 35
p = 0.914
Total 34
(48.57%)
(100.00%)
36
(51.43%)
(100.00%)
70
(100.00%)
(100.00%)
2.049
(1.770–2.372)
3.938
(3.287–4.719)
2.867
(2.497–3.293)
4.355 (31)
(3.759–4.950)
4.861 (36)
(4.395–5.327)
4.626 (67)
(4.260–4.994)
�Kg, geometric mean
��Mean Years
https://doi.org/10.1371/journal.pone.0221863.t014
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BIBD-positive snakes, however, it could also be explained by unknown factors related to NGS
library preparation. As we aimed to study the immune response using NP as the antigen, we
used the S segment primers of our previous study [1] in RT-PCRs to screen the pools, and
identified two additional S segments (S5-like and TSMV-2) within the pools. Screening of all
individual samples for UGV-like, S5-like, and TSMV-2 S segments by RT-PCR showed that
97.1% of the BIBD-positive snakes carried the UGV-like S-segment. This observation is well in
line with previous studies, in which we [1,11] and others [12] have observed that UGV-/
S6-like S segments are often found in snakes with BIBD. In contrast, we found the UGV-/
S6-like S segment only in 27.8% of the BIBD-negative snakes. As the mechanisms behind IB
formation are still unknown, one could speculate that UGV-/S6-like NP would be more prone
to IB formation. However, in our first report on reptarenaviruses in snakes, we purified IBs
Table 15. IgM ELISA cut-off point results against population parameters, univariate analysis including stratification by sex.
Sex
(Row%)
(Col%)
Weight�
(95% CI)
UGV-1: N = 69; UHV- NP, UHV-1 NP-C: N = 70
Age��(n)
(95% CI)
UGV-1: N = 66; UHV-1 NP, UHV-1 NP-C: N = 67
M F Total M F Total M F Total
UGV- 1
IgM ELISA
-ve
14
(41.18%)
(41.18%)
20
(58.82%)
(57.14%)
34
(100.00%)
(49.28%)
2.623
(2.204–3.120)
3.771
(2.867–4.962)
3.248
(2.712–3.889)
5.000 (13)
(3.983–6.017)
4.750 (20)
(4.145–5.355)
4.848 (33)
(4.338–5.359)
UGV-1
IgM ELISA
+ve
20
(57.14%)
(58.82%)
15
(42.86%)
(42.86%)
35
(100.00%)
(50.72%)
1.724
(1.424–2.087)
3.949
(3.089–5.048)
2.459
(2.008–3.011)
3.889 (18)
(3.167–4.610)
4.867 (15)
(4.060–5.674)
4.333 (33)
3.797–4.870)
Total 34
(49.28%)
100.00%)
35
(50.72%)
(100.00%)
69
(100.00%)
(100.00%)
2.049
(1.770–2.372)
3.938
(3.287–4.719)
2.820
(2.461–3.233)
4.355 (31)
(3.759–4.950)
4.800 (35)
(4.338–5.262)
4.595 (66)
(4.225–5.957)
χ2 = 1.7590, p = 0.185 t = 3.2678,
df = 32
p<0.01
t = -0.2540,
df = 33
p = 0.818
t = 2.0827,
df = 67
p<0.05
t = 1.968, df = 29
p = 0.0578
t = -0.2502,
df = 33
p = 0.8040
t = 1.417,
df = 67
p = 0.161
UHV-1 NP
IgM ELISA
-ve
27
(50.00%)
(79.41%)
27
(50.00%)
(75.00%)
54
(100.00%)
(77.14%)
2.042
(1.757–2.374)
3.841
(3.109–4.746)
2.801
(2.404–3.263)
4.280 (25)
(3.633–4.927)
4.778 (27)
(4.237–5.319)
4.538 (52)
(4.128–4.949)
UHV-1 NP
IgM ELISA
+ve
7
(43.75%)
(20.59%)
9
(56.25%)
(25.00%)
16
(100.00%)
(22.86%)
2.075
(1.212–3.553)
4.245
(2.764–6.521)
3.104
(2.183–4.413)
4.667 (6)
(2.603–6.730)
5.111 (9)
(3.994–6.228)
4.629 (15)
(4.034
(4.260–4.994)
χ2 = 0.1930, p = 0.660 t = -0.0881,
df = 32
p = 0.9304
t = -0.4807,
df = 34
p = 0.6338
t = -0.6185,
df = 68
p = 0.538
t = -0.5174,
df = 29
p = 0.6088
t = -0.6237,
df = 34
p = 0.5370
t = -0.893,
df = 65
p = 0.375
UHV-1
NP-C
IgM ELISA
-ve
21
(48.84%)
(61.76%)
22
(51.16%)
(61.11%)
43
(100.00%)
(61.43%)
2.155
(1.812–2.564)
3.754
(3.003–4.602)
2.863
(2.436–3.364)
4.350 (20)
(3.617–5.083)
4.682 (22)
(4.200–5.163)
4.524 (42)
(4.109–4.938)
UHV-1
NP-C
IgM ELISA
+ve
13
(48.15%)
(38.24%)
14
(51.85%)
(38.89%)
27
(100.00%)
(38.57%)
1.888
(1.414–2.521)
4.247
(3.018–5.978)
2.875
(2.204–3.750)
4.364 (11)
(3.152–5.576)
5.143 (14)
(4.134–6.152)
4.800 (25)
(4.065–4.994)
χ2 = 0.0032, p = 0.955 t = 0.8911,
df = 32
p = 0.3795
t = -0.6709,
df = 34
p = 0.5068
t = -0.295, df = 68
p = 0.797
t = -0.022, df = 29
p = 0.9826
t = -0.9792,
df = 34
p = 0.3344
t = -0.723,
df = 65
p = 0.472
Total 34
(48.57%)
(100.00%)
36
(51.43%)
(100.00%)
70
(100.00%)
(100.00%)
2.049
(1.770–2.372)
3.938
(3.287–4.719)
2.867
(2.497–3.293)
4.355 (31)
(3.759–4.950)
4.861 (36)
(4.395–5.327)
4.626 (67)
(4.260–4.994)
�Kg, geometric mean
��Mean Years
https://doi.org/10.1371/journal.pone.0221863.t015
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from infected cell cultures and used peptide mass fingerprinting to identify the main protein
component as University of Helsinki virus-1 (UHV-1) NP. This finding suggests that IB for-
mation is similar between different reptarenavirus species (or S segments). Thus one explana-
tion on why UGV-/S6-like S segments are often found in snakes with BIBD could instead lie in
the GPC that is also carried in the S segment. The origin and reservoir host(s) of reptarena-
viruses remain unknown, however, it seems obvious that UGV-/S6-like GPC allows the virus
to spread efficiently among boas. As IBs are found in various tissues, the UGV-/S6-like GPC
could also allow wide tissue tropism. Our findings indicated that detection of UGV-/S6-like S
segment had the closest substantial agreement (κ = 0.6878) with BIBD. However, further work
will be required to establish the sensitivity and specificity of UGV-/S6-like S segment detection
in BIBD diagnosis.
The reptile immune response is not known in great detail, and its description is often sub-
jected to a comparison with the mammalian immune system. It is also unclear how much
immune response mechanisms vary within the class Reptilia or even within the clade Ophidia
inside the order Squamata since studies on the immune response of snakes partially report
controversial findings, for instance regarding the increase in titres after repeated antigen expo-
sure in colubrid snakes [40]. Also, different IgY isotypes of certain snake species have been
described [37], and a secretory immunoglobulin has only been found in the bile of the north-
western garter snake (Thamnophis ordinoides) [44]. The fact that we studied samples collected
at a single time point from naturally infected snakes for which the time of infection was
unknown, made the evaluation of antibody response kinetics impossible. However, the analy-
sis of IgY and IgM antibodies by WB and ELISA showed that the presence of anti-UGV NP
IgY is negatively correlated to the presence of IB and thereby BIBD (Fig 2). Although GPC and
NP are encoded by the S segment, it remains to be studied whether GPC induces a similar
immune response. We could not detect anti-GPC antibodies by WB, however, the result most
likely reflects lack of sensitivity rather than lack of antibodies since we used purified virions
(the NP is by far the most prominent protein in the virion) as the antigen. Further evidence of
a possible association between infection with a virus bearing UGV-/S6-like S segment and
BIBD is the observation that we found a significant positive association between weight and
plasma UGV1 IgY titres. The observed variable occurrence of IgY and IgM antibodies in indi-
vidual snakes could be due to the prolonged persistence of IgM and the variable onset of IgY
production [21,39]. Anti-UGV NP IgM antibody titres showed a trend to lower in the older
BIBD-negative snakes, which could reflect exhaustion of the immune system or a gradual class
switch towards IgY. The current knowledge on the role of IgM and its age dependency in pro-
tective immunity in snakes is scarce. Natural antibodies (NAbs) are thought to compensate the
decreasing sensitivity of the adaptive immune system in ageing snakes [45]. Interestingly,
NAbs are also suggested to provide protection against mammarenavirus (LCMV) infection by
epitope recognition [46].
The timing of infection greatly influences the immune response, as shown for LCMV, the
prototypic arenavirus. Exposure in utero or as a neonate results in chronic infections [1,47].
Persistently infected LCMV carriers were thought to develop a state of tolerance, accepting the
virus as endogenous, and therefore do not respond by antibody production [48]. However,
later studies demonstrated an immunological response towards LCMV and concluded that
low antibody levels were due to the formation of immune complexes that were deposited in
the glomeruli of the kidney [49]. Further studies are needed to demonstrate whether such
immune complexes are present in snakes with BIBD and/or in snakes infected with reptarena-
viruses in utero or as neonates. Several studies also elucidated a dependency of antibody pro-
duction on different strains of viruses and mice and a different IgG isotype profile in chronic
vs. acute murine infections [50]. These antibody profiles were attributed to involvement of
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different T cell populations in acute and chronic infections, and associated with varying clini-
cal signs [50]. Extensive studies by Oldstone and colleagues with the LCMV Armstrong 53b
strain (ARM) as the parental virus demonstrated the emergence of virus variants with varying
tissue tropism in mice [51]. Infection with the parental ARM isolate induced a strong CD8+ T
cell response, while the CD8+ T cell response was aborted in mice infected with clone 13 (Cl
13) isolated from lymphoid cells of neonate mice infected with ARM [51]. LCMV strains and
variants with high affinity for α-dystroglycan (e.g. Cl 13), the cellular receptor for Old World
mammarenaviruses [52], can enter dendritic cells (DCs) [51]. Infected DCs can then be
destroyed by the antiviral CD8+ T cell response [53] or remain functionally impaired [51]. The
loss of the DC function as professional antigen presenting cells significantly contributes to the
overall immunosuppression seen as a consequence of LCMV infection [51]. The receptor and
the ability of reptarenaviruses to infect DCs are currently unknown. However, like LCMV
[54], reptarenaviruses infect lymphoid cells [55], and could thus use immunosuppression
mechanisms similar to those employed by LCMV. One could also speculate that the swarm of
S segments often found in snakes with BIBD would contribute to immunosuppression by
enabling a broader cell tropism for the virus.
Another aspect of LCMV induced immunosuppression is the exhaustion of CD4+ and
CD8+ T cells that occurs in chronically LCMV infected mice [56,57]. Furthermore, the func-
tional impairment of CD4+ T cells negatively influences the antibody response [56,57]. Also,
the exhaustion of CD4+ T cells reduces the production of antibodies, as demonstrated by pro-
viding virus-specific CD4+ T cells from transgenic mice to chronically infected animals [56].
Mice persistently infected with LCMV do not possess LCMV-specific CD8+ T cells [50], and
CD4+ T cells are absent in transplacentally infected mice [57]. The attenuation of T cell depen-
dent immune functions as well as immune complex formation support the assumption that
animals infected via vertical transmission show lower antibody levels than horizontally
infected animals. It is possible that vertical transmission also occurs for maternal antibodies in
ovoviviparous snakes, such as B. constrictor. This could theoretically compensate for the
embryo’s immunological incompetence; however, how this aligns with the fact that persis-
tently infected mothers pass both their reptarena- [1] and hartmaniviruses [10] to the newborn
is not clear. Many snakes examined in the present study are related, as they represent a breed-
ing colony; therefore, it is not possible to determine how many were horizontally infected. It is
tempting to speculate that the snakes with high antibody titres were horizontally infected,
whereas the BIBD-positive animals with low antibody titres were vertically infected. This
would tie in with observations on LCMV which leads to reduced levels of IgG2a subclass in
persistently infected mice [50]. LCMV Cl 13 can induce persistent infection, which results in
exhaustion of virus-specific T cells and is associated with generalized immunosuppression in
adult mice [51]. Something similar could occur during reptarenavirus infection. It is possible
that there are reptarenavirus S segments with point mutations, similar to that in LCMV Cl 13
that alter the cell tropism and contribute to immunosuppression. Alternatively, multiple S seg-
ments could allow infection of different subsets of lymphoid cells, thus resulting in immuno-
suppression similar to that of LCMV Cl 13. In addition to the antibody and T cell responses,
reptarenaviruses can be expected to influence the innate immune system in a manner similar
to that of mammarenaviruses, i.e. via inhibition of type I interferon production [10,17,18,58].
Indeed, a general reptarenavirus-induced immunosuppression would tie in with the increased
incidence of bacterial infections and/or neoplastic processes in snakes with BIBD [2–4].
This is to our knowledge the first report to thoroughly assess the adaptive immune response
of boid snakes towards reptarenaviruses. By characterising a single breeding collection, we
could demonstrate that one individual virus, UGV-/S6-like S segment, was strongly associated
with BIBD. Supporting the link between the presence of UGV-/S6-like S segment and BIBD,
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we found a negative correlation between BIBD and the presence of anti-UGV NP antibodies.
Future studies, either longitudinal or experimental infection driven, are needed to understand
the kinetics of the antibody response in snakes with reptarenavirus infection. Our results do,
however, suggest that presence/absence of UGV-/S6-like S segment RNA and presence/
absence of anti-UGV NP IgY antibodies could serve to a limited extent in the ante mortem
diagnostics of BIBD.
Materials and methods
Study cohort and samples, cytological examination
We studied a breeding collection of 70 Boa constrictor snakes comprising 36 female and 34
male adult individuals, aged between two and eight years (Table 1). Husbandry conditions
included humidity of approximately 60% and a season-dependent light regime with photoperi-
ods of 12–13 hours during warm and 9–10 hours during cold months. Female snakes were
kept at an environmental temperature of 26–33˚C with a drop of 3–4˚C during night, but not
deceeding 24˚C whereas the males were kept at an environmental temperature approximately
2–5˚C lower than the females with a minimum temperature of 23˚C The cohort included two
debilitated snakes (one male, animal 1.20; one female, animal 1.29) and one female snake with
cloacal prolapse (animal 1.18); the remaining animals were clinically healthy. In June 2015,
one snake from the collection had been euthanised due to clinical signs, and post mortem
examination had confirmed BIBD diagnosis. Subsequent analysis of blood samples from 14
snakes had revealed the presence of cytoplasmic IBs in blood cells of eight snakes, confirmed
that they also suffered from BIBD. These findings prompted the owner to have the entire
breeding colony tested for BIBD a year later. In July 2016, blood samples were collected in 1.3
ml K3E EDTA tubes (Sarstedt) by either caudal tail vein venipuncture or cardiocentesis. All
snakes were weighed before bleeding. No ethical permissions were required for these diagno-
sis-motivated blood samplings.
Blood samples and smears
Cytological examination of blood smears, which presents the current standard ante mortem
diagnostic tool [3,59], served to confirm BIBD diagnosis. We prepared two blood smears for
each animal, stained with May-Gru¨nwald-Giemsa, and used light microscopy for IB detection
in blood cells as described [1]. From the remaining blood, ca. 1 ml each, we separated plasma
by centrifugation at 1,200 x g for 2 min, and stored the cell-enriched blood and plasma at
-80˚C.
Next generation sequencing (NGS)
NGS served to identify the “reptarenavirome” of the breeding collection, and to allow the set-
ting up of virus-specific RT-PCRs for screening of the entire collection. For NGS, we prepared
two pooled samples of cell-enriched blood: 1. three snakes without evidence of BIBD (no IBs
in blood cells), 2. three snakes with confirmed BIBD (abundant IBs in blood cells), and per-
formed RNA extraction, NGS library preparation, and genome assembly as described [1,60].
Reverse transcriptase-polymerase chain reaction (RT-PCR)
We were interested in sequencing the S segments present in the breeding colony, since the S
segment bears the NP which we used as the antigen in the antibody assays. As we only recov-
ered a single complete reptarenavirus S segment (University of Giessen virus-1, UGV-1, Gen-
Bank accession MH483061) by NGS and de novo assembly [10], we decided to use the virus-
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specific primers of our previous study [1] to screen three additional RNA pools prepared from
blood samples by RT-PCR: one BIBD-negative (no evidence of IB in blood cells) and two
BIBD-positive. By this approach, we detected: University of Giessen virus-like (UGV-2 and
UGV-3, primers [1]), S5-like (S5-like, primers [1]), and Tavallinen suomalainen mies virus-2
(TSMV-2, primers [1]) S segments in the BIBD-positive RNA pools; and S5-like and TSMV-2
S segments in the BIBD-negative RNA pool. We then used these three primer pairs to screen
blood samples of the entire collection by RT-PCR. Additionally, we screened the collection by
RT-PCR with primers targeting the L segments of two hartmaniviruses identified by NGS and
de novo assembly in the BIBD positive pool, i.e. Old Schoolhouse viruses 1 and 2 (OScV-1,
OScV-2) described in a previous study [10].
We did RNA extractions from cell-enriched EDTA blood (100 μl) as described [1], but
introduced a mechanical homogenization step using a Retsch MM300 TissueLyser (QIAGEN)
for 2 min at highest frequency (30 Hertz). The following primers were used: UGV-2 and -3 S
segment (Fwd 5’-ATAAGGTCAGGGTATAACTTGG-3’ and Rev 5’-GAACTTGGCATAA
AAATACAAATGAATG-3’), S5-like S segment (Fwd 5’-GTCAGGATAGAGTCTGGGAGCAT-
3’ and Rev 5’-TGAACATTCAGAGGGAATTTGGCATC-3’), TSMV-2 S-segment (Fwd 5’-
CAAGTCTGGATAAAGTCTTGGTGCAT-3’ and Rev 5’-GTAATTGATGACGACAATAGG
GTCGA-3’), OScV-1 L segment (Fwd 5´- GCACTAAGTGGATCATCAAC-3´ and Rev 5´-
CATGCAAACCTGTTGCTG-3´), and OScV-2 L segment (Fwd 5´- GCACTAAGTGGATCATC
AAC-3´ and Rev 5´-GAACAATGTCATAACTTGCTC-3´); RT-PCR was performed as
described [1], the amplicons analysed by agarose gel electrophoresis, and the bands visualised
by GelRed Nucleic Acid Gel Stain (BIOTIUM) under UV-light with the UVP BioDoc-It Imag-
ing System (Thermo Fisher Scientific). The GeneRuler 100 bp DNA ladder (Thermo Fisher
Scientific) served as the marker.
Western blot (WB)
We used UGV-1 virions concentrated by ultracentrifugation through a sucrose cushion, pre-
pared as described in [7], as the antigen in WB. We did the WBs with plasma samples as
described in [14], but blocked the nitrocellulose membranes for 3–4 h instead of 30 min at
room temperature. We used snake plasma at 1:200 dilution, and the affinity purified unlabelled
anti-IgM and anti-IgY antibodies [14] at respective dilutions of 1:500 and 1:1000. We evalu-
ated the results recorded using the Odyssey CLx Infrared Imaging System (LI-COR Biosci-
ences) as negative (–), weakly positive (+), moderately positive (++), and strongly positive
(+++) according to the signal intensity.
Enzyme-linked immunosorbent assay (ELISA)
We set up an ELISA to measure the IgM and IgY levels in the plasma samples using concen-
trated UGV-1 virions (inactivated with 1% Triton X-100 [Fluka BioChemika]), and recombi-
nant UHV-1 NP and UHV-1 NP-C (described in [61]) as the antigens. We diluted the
antigens (UGV-1 at 1:400, UHV-1 NP and UHV-1 NP-C at 2 μg/ml) in 0.05M carbonate
buffer, pH 9.6, and used 100 μl/well to coat Nunc Microplate Immuno Polysorp (Thermo Sci-
entific) plates by overnight incubation on an orbital shaker at 4˚C. After coating, we used 1%
BSA in PBS (150 μl/well) for blocking (2 h at 37˚C), washed once with TBS-T (TBS + 0.05%
Tween-20) prior to incubation (1 h at 37˚C) with the plasma samples diluted (1:200 used for
UHV-1 NP-C, and 1:400 for UHV-1 NP and UGV-1) in 0.25% BSA/PBS. After four TBS-T
washes, we incubated (45 min at 37˚C) the plates with 100 μl/well of horseradish peroxidase
(HRP) labelled anti-boa IgM or anti-boa IgY antibodies, described in [14], diluted 1:2000 in
0.25% BSA/PBS, washed four times with TBS-T, incubated (20 min at RT) with TMB Substrate
Antibodies in BIBD
PLOS ONE | https://doi.org/10.1371/journal.pone.0221863 September 9, 2019 24 / 28
Solution (Thermo Scientific) 100 μl/well, terminated the reaction by addition of 1M H2SO4
50 μl/well, and read the results (OD at 450 nm) with a BioTek Synergy HT Multi-Mode Micro-
plate Reader.
We performed change point analysis utilising the changepoint v.2.2.2 package (https://rdrr.
io/cran/changepoint/) in R to set the cut-off values (separately for IgM and IgY and for each
antigen) for distinguishing positive and negative ELISA results. Briefly, we used the cpt.mean-
var function with the AMOC method on the ELISA data arranged in ascending order. We set
the cut-offs (UHV NP IgY = 0.31; UHV NP IgM = 0.35; UGV-1 IgY = 0.27; UGV-1 IgM =
0.48; UHV NP-C IgY = 0.47; and UHV NP-C IgM = 0.37) just above the detected change
point, so that the value at change point was considered negative.
Statistical analysis
We performed data analysis using Stata Statistical Software: Release 13. College Station, TX:
StataCorp LP. The analysis examined possible associations between test results and population
parameters using univariate and multivariable analysis. For data that were not normally dis-
tributed, we utilised non-parametric tests. Given the nature of the investigation and the study
population, the analysis is predominantly descriptive. Sensitivity and specificity calculations
for the different tests were used as indicative since the study was not designed for the purpose.
Cohen’s kappa (κ) and weighted kappa κ (w) served to examine the agreement between tests
with binary or ordinal data [42].
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